Literature DB >> 7812784

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

J L Cadet1, B Ladenheim, I Baum, E Carlson, C Epstein.   

Abstract

We have used female and male transgenic (Tg) mice that carry the complete sequence of the human copper-zinc (CuZn) superoxide dismutase (SOD) gene in order to assess the lethal effects of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). In contrast to non-Tg mice, both heterozygous and homozygous SOD-Tg mice showed resistance to the lethal effects of both drugs. Females of both SOD-Tg and non-Tg strains were somewhat more resistant to the effects of these drugs in comparison to males. In general, homozygous animals show greater resistance to the effects of the two drugs. These results suggest that the acute lethal effects of amphetamine-substituted analogs might involve the intracellular overproduction of the superoxide radicals secondary to hypoxic injury. The gender differences suggest that there might be hormonal-free radical scavenger interactions that offer better protection to female mice. This might be related both to the lifespan of and to the lower prevalence of Parkinson's disease in women. Future studies will need to address these issues further.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812784     DOI: 10.1016/0006-8993(94)91624-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

2.  Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

Authors:  Winnie Jeng; Peter G Wells
Journal:  ACS Chem Neurosci       Date:  2010-02-23       Impact factor: 4.418

3.  Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.

Authors:  Sylvia K Shenouda; Kurt J Varner; Felix Carvalho; Pamela A Lucchesi
Journal:  Cardiovasc Toxicol       Date:  2009-03-31       Impact factor: 3.231

Review 4.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

Review 5.  Mechanisms of neuroprotection by estrogen.

Authors:  Shotaro Suzuki; Candice M Brown; Phyllis M Wise
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  CD200 attenuates methamphetamine-induced microglial activation and dopamine depletion.

Authors:  Xia Yue; Dongfang Qiao; Aifeng Wang; Xiaohui Tan; Yanhong Li; Chao Liu; Huijun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

Review 7.  Serotonin neurotoxins--past and present.

Authors:  H G Baumgarten; L Lachenmayer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 8.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

9.  Catechol-o-methyltransferase and 3,4-({+/-})-methylenedioxymethamphetamine toxicity.

Authors:  Joseph M Herndon; Aram B Cholanians; Lucina E Lizarraga; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-03-03       Impact factor: 4.849

Review 10.  Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.

Authors:  Mrinmay Chakrabarti; Azizul Haque; Naren L Banik; Prakash Nagarkatti; Mitzi Nagarkatti; Swapan K Ray
Journal:  Brain Res Bull       Date:  2014-09-20       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.